Jason Gerberry
Stock Analyst at Bank of America Securities
(4.89)
# 277
Out of 4,442 analysts
860
Total ratings
59.9%
Success rate
19.6%
Average return
Main Sectors:
Stocks Rated by Jason Gerberry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EXEL Exelixis | Maintained: Sell | $41 | $51.34 | -20.14% | 35 | Jun 22, 2026 | |
| ABBV AbbVie | Maintained: Buy | $234 | $234.76 | -0.32% | 12 | Jun 22, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $111 | $75.99 | +46.07% | 44 | Jun 11, 2026 | |
| JAZZ Jazz Pharmaceuticals | Reiterated: Buy | $275 → $307 | $230.25 | +33.33% | 70 | Jun 10, 2026 | |
| JNJ Johnson & Johnson | Maintained: Hold | $254 | $239.08 | +6.24% | 10 | Jun 4, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $130 | $119.60 | +8.70% | 14 | Jun 2, 2026 | |
| OCS Oculis Holding AG | Maintained: Buy | $44 → $35 | $11.72 | +198.63% | 18 | Jun 1, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Buy | $80 | $56.50 | +41.59% | 14 | May 29, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Buy | $1,251 | $1,107.08 | +13.00% | 15 | May 26, 2026 | |
| IMVT Immunovant | Maintained: Buy | $32 → $43 | $37.62 | +14.30% | 18 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $67 | $55.53 | +20.66% | 12 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $74.04 | - | 18 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.827 | +141.84% | 14 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $31 | $5.75 | +439.13% | 12 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 → $62 | $55.35 | +12.01% | 7 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $51.96 | - | 30 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $66.17 | - | 20 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $25.61 | - | 2 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $214 → $276 | $241.97 | +14.06% | 28 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $33.21 | +20.45% | 81 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $81 → $93 | $79.90 | +16.40% | 20 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $48.07 | - | 39 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $27 → $26 | $24.72 | +5.18% | 11 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $569 → $626 | $544.33 | +15.00% | 19 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $77 | $54.61 | +41.00% | 14 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $16.37 | +16.07% | 2 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $32 → $28 | $34.16 | -18.03% | 15 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $7.10 | $6.82 | +4.16% | 20 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $13.45 | - | 15 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 | $15.75 | -36.51% | 40 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $1 | $1.80 | -44.44% | 11 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $31.40 | +11.46% | 14 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $14.78 | -32.34% | 13 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $19.53 | - | 14 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $25.36 | - | 1 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $25 → $28 | $29.05 | -3.61% | 18 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $17.44 | -13.99% | 18 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.46 | n/a | 7 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.07 | n/a | 6 | Sep 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $4 → $3.5 | $2.42 | n/a | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $4 → $2 | $6.84 | n/a | 10 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $5 → $1 | $1.61 | n/a | 4 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $8.10 | n/a | 1 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $26 → $10 | $5.65 | n/a | 2 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $0.65 | n/a | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $110 | $288.18 | n/a | 1 | Nov 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $6 | $0.0001 | n/a | 3 | Aug 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $135.00 | n/a | 2 | Jun 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $9 | $2.15 | n/a | 1 | Oct 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $18 | $6.18 | n/a | 7 | Nov 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $0.4186 | n/a | 13 | Nov 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $59 → $37 | $23.51 | n/a | 7 | Nov 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $110 → $81 | $9.49 | n/a | 9 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $33 → $24 | $16.66 | n/a | 7 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $47.42 | n/a | 1 | Aug 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $14 | $3.86 | n/a | 9 | Aug 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 | $161.44 | n/a | 1 | Jul 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.008 | n/a | 3 | Jan 19, 2016 |
Exelixis
Jun 22, 2026
Maintained: Sell
Price Target: $41
Current: $51.34
Upside: -20.14%
AbbVie
Jun 22, 2026
Maintained: Buy
Price Target: $234
Current: $234.76
Upside: -0.32%
Ionis Pharmaceuticals
Jun 11, 2026
Reiterated: Buy
Price Target: $111
Current: $75.99
Upside: +46.07%
Jazz Pharmaceuticals
Jun 10, 2026
Reiterated: Buy
Price Target: $275 → $307
Current: $230.25
Upside: +33.33%
Johnson & Johnson
Jun 4, 2026
Maintained: Hold
Price Target: $254
Current: $239.08
Upside: +6.24%
Merck & Co.
Jun 2, 2026
Reiterated: Buy
Price Target: $130
Current: $119.60
Upside: +8.70%
Oculis Holding AG
Jun 1, 2026
Maintained: Buy
Price Target: $44 → $35
Current: $11.72
Upside: +198.63%
BioMarin Pharmaceutical
May 29, 2026
Reiterated: Buy
Price Target: $80
Current: $56.50
Upside: +41.59%
Eli Lilly and Company
May 26, 2026
Reiterated: Buy
Price Target: $1,251
Current: $1,107.08
Upside: +13.00%
Immunovant
May 21, 2026
Maintained: Buy
Price Target: $32 → $43
Current: $37.62
Upside: +14.30%
May 20, 2026
Reiterated: Buy
Price Target: $67
Current: $55.53
Upside: +20.66%
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $74.04
Upside: -
May 14, 2026
Reiterated: Buy
Price Target: $2
Current: $0.827
Upside: +141.84%
May 12, 2026
Maintained: Buy
Price Target: $29 → $31
Current: $5.75
Upside: +439.13%
May 7, 2026
Maintained: Buy
Price Target: $54 → $62
Current: $55.35
Upside: +12.01%
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $51.96
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $66.17
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $25.61
Upside: -
May 4, 2026
Reiterated: Buy
Price Target: $214 → $276
Current: $241.97
Upside: +14.06%
Apr 30, 2026
Reiterated: Buy
Price Target: $40
Current: $33.21
Upside: +20.45%
Apr 20, 2026
Maintained: Buy
Price Target: $81 → $93
Current: $79.90
Upside: +16.40%
Apr 9, 2026
Maintained: Hold
Price Target: n/a
Current: $48.07
Upside: -
Apr 9, 2026
Maintained: Hold
Price Target: $27 → $26
Current: $24.72
Upside: +5.18%
Mar 30, 2026
Reiterated: Hold
Price Target: $569 → $626
Current: $544.33
Upside: +15.00%
Mar 9, 2026
Reiterated: Buy
Price Target: $50 → $77
Current: $54.61
Upside: +41.00%
Mar 3, 2026
Reiterated: Buy
Price Target: $19
Current: $16.37
Upside: +16.07%
Feb 24, 2026
Reiterated: Sell
Price Target: $32 → $28
Current: $34.16
Upside: -18.03%
Feb 18, 2026
Reiterated: Sell
Price Target: $7.10
Current: $6.82
Upside: +4.16%
Feb 13, 2026
Maintained: Sell
Price Target: n/a
Current: $13.45
Upside: -
Jan 14, 2026
Maintained: Sell
Price Target: $10
Current: $15.75
Upside: -36.51%
Jan 12, 2026
Maintained: Sell
Price Target: $1
Current: $1.80
Upside: -44.44%
Dec 8, 2025
Maintained: Buy
Price Target: $35
Current: $31.40
Upside: +11.46%
Nov 10, 2025
Reiterated: Hold
Price Target: $10
Current: $14.78
Upside: -32.34%
Nov 7, 2025
Maintained: Hold
Price Target: n/a
Current: $19.53
Upside: -
Nov 7, 2025
Maintained: Sell
Price Target: n/a
Current: $25.36
Upside: -
Nov 6, 2025
Reiterated: Sell
Price Target: $25 → $28
Current: $29.05
Upside: -3.61%
Nov 6, 2025
Reiterated: Buy
Price Target: $15
Current: $17.44
Upside: -13.99%
Oct 30, 2023
Rated: Hold
Price Target: n/a
Current: $1.46
Upside: n/a
Sep 28, 2023
Rated: Hold
Price Target: n/a
Current: $2.07
Upside: n/a
Aug 9, 2023
Maintained: Sell
Price Target: $4 → $3.5
Current: $2.42
Upside: n/a
Aug 8, 2023
Downgraded: Sell
Price Target: $4 → $2
Current: $6.84
Upside: n/a
Jan 5, 2023
Maintained: Sell
Price Target: $5 → $1
Current: $1.61
Upside: n/a
May 17, 2022
Maintained: Buy
Price Target: $11
Current: $8.10
Upside: n/a
Jul 15, 2020
Downgraded: Hold
Price Target: $26 → $10
Current: $5.65
Upside: n/a
Mar 11, 2020
Initiated Coverage: Buy
Price Target: $32
Current: $0.65
Upside: n/a
Nov 13, 2019
Initiated Coverage: Buy
Price Target: $110
Current: $288.18
Upside: n/a
Aug 20, 2019
Maintained: Buy
Price Target: $5 → $6
Current: $0.0001
Upside: n/a
Jun 28, 2019
Downgraded: Sell
Price Target: n/a
Current: $135.00
Upside: n/a
Oct 16, 2018
Downgraded: Sell
Price Target: $9
Current: $2.15
Upside: n/a
Nov 20, 2016
Reiterated: Buy
Price Target: $14 → $18
Current: $6.18
Upside: n/a
Nov 15, 2016
Reiterated: Buy
Price Target: $34
Current: $0.4186
Upside: n/a
Nov 2, 2016
Reiterated: Hold
Price Target: $59 → $37
Current: $23.51
Upside: n/a
Aug 10, 2016
Reiterated: Hold
Price Target: $110 → $81
Current: $9.49
Upside: n/a
Aug 9, 2016
Reiterated: Hold
Price Target: $33 → $24
Current: $16.66
Upside: n/a
Aug 8, 2016
Maintained: Hold
Price Target: n/a
Current: $47.42
Upside: n/a
Aug 5, 2016
Reiterated: Hold
Price Target: $10 → $14
Current: $3.86
Upside: n/a
Jul 13, 2016
Maintained: Buy
Price Target: $70
Current: $161.44
Upside: n/a
Jan 19, 2016
Downgraded: Hold
Price Target: n/a
Current: $0.008
Upside: n/a